APA (7th ed.) Citation

Wada, N., Murakami, T., Fauzi, M., Sakaki, K., Oshima, S., Shimada, Y., . . . Harada, N. (2024). Elevated Serum Growth Differentiation Factor 15 Levels as a Potential Biomarker of the Efficacy of Imeglimin in Individuals With Type 2 Diabetes Mellitus: An Exploratory Study. Journal of clinical medicine research, 16(10), 503-508. https://doi.org/10.14740/jocmr6031

Chicago Style (17th ed.) Citation

Wada, Naoki, et al. "Elevated Serum Growth Differentiation Factor 15 Levels as a Potential Biomarker of the Efficacy of Imeglimin in Individuals With Type 2 Diabetes Mellitus: An Exploratory Study." Journal of Clinical Medicine Research 16, no. 10 (2024): 503-508. https://doi.org/10.14740/jocmr6031.

MLA (9th ed.) Citation

Wada, Naoki, et al. "Elevated Serum Growth Differentiation Factor 15 Levels as a Potential Biomarker of the Efficacy of Imeglimin in Individuals With Type 2 Diabetes Mellitus: An Exploratory Study." Journal of Clinical Medicine Research, vol. 16, no. 10, 2024, pp. 503-508, https://doi.org/10.14740/jocmr6031.